课题基金 / 基金详情

PERTUSSIS TOXIN--AN APPROACH TO A NEW PERTUSSIS VACCINE

PERTUSSIS TOXIN--AN APPROACH TO A NEW PERTUSSIS VACCINE
百日咳毒素——新型百日咳疫苗的开发方法
批准号:
4693835
负责人:
R D SEKURA
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

R D SEKURA的其他基金

相似基金

相关文献

中文摘要
翻译
百日咳的发病率已得到控制,通过使用我们目前的整体 细胞百日咳疫苗。 百日咳鉴定的新进展 毒素(PT)作为抗百日咳的主要保护性抗原, 有机会生产一种安全性和有效性更高的新疫苗。 项目Z01 HD 01302旨在表征生物化学作用 目前的项目集中于开发 PT的生产,以及中和毒性作用的方法, 评估对由此中和的毒素的免疫应答。 增长 PT规模生产的条件和纯化方法 适合人类使用。 B。百日咳培养在一个100 1 发酵罐,产量超过200毫克的纯化PT。 PT的水平 生产使实验疫苗的制备成为现实, 足够的数量以进行临床试验。 的测定方法 毒性监测和毒性中和 疫苗的研制工作已经完成。 此外,方法已经 用于监测类毒素PT的残留抗原性 制备,并监测小鼠,猴, 和人类,并测量疫苗在小鼠和组织中的效力, 文化 已经开发出实验性百日咳疫苗, 只有最低水平的残留毒性活性,而抗原活性 只是部分减少。 通过吸收 氢氧化铝上百日咳类毒素具有高度抗原性, PT特异性免疫应答。 用这种百日咳类毒素免疫 保护小鼠免受细菌和毒素的攻击, 在CHO细胞试验中中和PT的抗体。 这些数据预测 该百日咳类毒素将有效预防百日咳。
英文摘要
The incidence of pertussis has been controlled by use of our current whole cell pertussis vaccines. Recent advances in identification of pertussis toxin (PT) as a major protective antigen against pertussis affords and opportunity to produce a new vaccine with improved safety and efficacy. Project Z01 HD 01302 is directed at characterizing the biochemical action of PT; the current project concentrates on development of mnethods for production of PT, as well as methods for neutralization of toxic action and assessing the immune response to toxins thus neutralized. Growth conditions and purification methods scale production of PT under conditions that are suitable for human usage. B. pertussis cultivated in a 100 1 fermentator, yields more than 200 mg of purified PT. This level of PT production makes practical the preparations of experimental vaccines in sufficient quantities to permit clinical trail. Assay methods for monitoring the toxicity and neutralization of toxicity of experimental vaccine preparation have been established. In addition, methods have been established to monitor the retained antigenicity of toxoided PT preparations, and to monitor immue response to PT-toxoids in mice, monkeys, and humans, and also to measure vaccine efficacy in mice and tissue culture. Experimental pertussis vaccines have been developed which show only minimal levels of residual toxic activities, while antigenic activity is only partially reduced. Experimental vaccines prepared by absorption of pertussis toxoid onto aluminum hydroxide are highly antigenic and elicit a PT specific immune response. Immunization with this pertussis toxoid protects mice against both bacterial and toxin challenge, elicits serum antibodies which neutralizes PT in the CHO cell assay. These data predict that this pertussis toxoid will be effective in the prevention of pertussis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PERTUSSIS TOXIN--AN APPROACH TO A NEW PERTUSSIS VACCINE
PERTUSSIS HEAT LABILE TOXIN (HLT)--ISOLATION AND CHARACTERIZATION
TOXINS OF PERTUSSIS--ISOLATION, CHARACTERIZATION AND MECHANISMS OF ACTION
PERTUSSIS HEAT LABILE TOXIN (HLT)--ISOLATION AND CHARACTERIZATION
海外基金